The Lebanon Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Lebanon Healthcare Journal.

Press releases published on October 15, 2026

22 minutes ago

Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26

Indeterminate GlobeNewswire

22 minutes ago

Callio Therapeutics Wins Best New ADC Drug Developer at the 13th World ADC Awards, Presents Across Five Sessions at World ADC San Diego

Indeterminate GlobeNewswire

22 minutes ago

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire

22 minutes ago

Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy

Indeterminate GlobeNewswire

22 minutes ago

Nema Health Expands Access to Specialized PTSD Treatment Through Evernorth Behavioral Health Network

Indeterminate GlobeNewswire

22 minutes ago

Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy

Indeterminate GlobeNewswire

22 minutes ago

IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference

Indeterminate GlobeNewswire

22 minutes ago

Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support

Indeterminate GlobeNewswire

22 minutes ago

Claris Biotherapeutics to Host Virtual KOL Event on Positive CSB-001 Data and the Unmet Need in Limbal Stem Cell Deficiency (LSCD)

Indeterminate GlobeNewswire

22 minutes ago

Humacyte Provides Commercial Update and Highlights Rapid Acceleration of Symvess Adoption by Hospitals

Indeterminate GlobeNewswire

22 minutes ago

Eupraxia Pharmaceuticals Reaches its Enrollment Target for the RESOLVE Trial Investigating EP-104GI for the Treatment of Eosinophilic Esophagitis

Indeterminate GlobeNewswire

22 minutes ago

ORYZON further strengthens vafidemstat’s patent portfolio with new decisions to grant

Indeterminate GlobeNewswire

22 minutes ago

Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer

Indeterminate GlobeNewswire

22 minutes ago

PETVIVO ANNOUNCES RELEASE OF TWO REASEARCH ABSTRACTS AND UPCOMING CONFERENCE PRESENTATIONS ON OSTEOARTHRITIS IN RHESUS MACAQUES

Indeterminate GlobeNewswire

22 minutes ago

First Tracks Biotherapeutics Announces $200 Million Private Placement

Indeterminate GlobeNewswire

22 minutes ago

Jyong Biotech Announces Proposed Texas Facility to Support Potential Commercialization of Its Drug Candidates

Indeterminate GlobeNewswire

32 minutes ago

PA Nonprofit Launches New Women’s Health Innovation Program to Close Gaps in Healthcare Innovation

Indeterminate GlobeNewswire

33 minutes ago

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

Indeterminate GlobeNewswire

an hour ago

Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors

Indeterminate GlobeNewswire

an hour ago

Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference

Indeterminate GlobeNewswire